Evaluation of a New Anti-cancer Vaccine for Patients With Non-small Cell Lung Cancer, After Tumor Removal by Surgery

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT01159964
Recruitment Status : Terminated (Study termination due to negative Phase III of another study product from same technology platform.)
First Posted : July 12, 2010
Last Update Posted : May 15, 2017
Information provided by (Responsible Party):